Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Names Alacris CSP for Target Enrichment

NEW YORK (GenomeWeb) – Agilent Technologies today said it named Alacris Theranostics an Agilent Certified Service Provider for target enrichment. 

Alacris is based in Berlin and provides molecular analysis and bioinformatics through an approach called ModCell, which is intended to match patients with appropriate therapies. According to Agilent, Alacris exploits next-generation sequencing and other omics data to facilitate drug development and personalized medicine in cancer and other complex diseases. 

ModCell was developed at the Max Planck Institute for Molecular Genetics and is exclusively licensed to Alacris. 

For its CSP program, Agilent chooses companies that will leverage Agilent's technologies in providing analysis services. Agilent trains the firms on its workflow to ensure that customers receive consistent data quality, reproducibility, and reliability, it said. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.